1,051 results match your criteria: "Women's Health Institute[Affiliation]"
Gynecol Oncol
November 2023
Johns Hopkins University School of Medicine, Department of Gynecology and Obstetrics Oncology, and Pathology, USA.
Objective: To evaluate the safety, tolerability, and efficacy of topical artesunate ointment for treatment of biopsy-confirmed Human papillomavirus (HPV)-associated Vulvar intraepithelial neoplasia (VIN) 2/3.
Methods: Participants were enrolled on a prospective, IRB-approved, dose-escalation phase I trial testing either 1, 2 or 3 treatment cycles (5 days), every other week, as applicable. Clinical assessments were completed prior to each dose cycle and included exam and review of adverse event (AE) diary cards.
J Sex Med
November 2023
Center for Urogynecology & Pelvic Reconstructive Surgery, Women's Health Institute, Cleveland Clinic, Cleveland, OH, United States.
Background: Pelvic pain has been reported in transmasculine individuals taking testosterone. There is a need for further investigation to increase understanding of the prevalence and risk factors of this pain.
Aim: We sought to determine the prevalence of pelvic pain reported by transmasculine individuals who had both a uterus and ovaries and were taking testosterone.
Urogynecology (Phila)
April 2024
From the Center for Urogynecology and Pelvic Reconstructive Surgery, Women's Health Institute.
Importance: As few studies exist examining postoperative functional outcomes in patients undergoing robotic sacrocolpopexy and ventral rectopexy, results from this study can help guide surgeons in counseling patients on their outcomes.
Objective: The aim of the study was to evaluate functional outcomes and overall postoperative satisfaction as measured by the Pelvic Floor Disability Index 20 (PFDI-20), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), and Patient Global Impression of Improvement Scale (PGI-I) in patients who underwent combined robotic ventral rectopexy and sacrocolpopexy for concomitant pelvic organ prolapse (POP) and rectal prolapse or intussusception (RP/I).
Methods: This was a retrospective cohort and survey study of patients with combined POP and RP/I who underwent the previously mentioned surgical repair between January 2018 and July 2021.
Urogynecology (Phila)
October 2023
Division of Gynecologic Specialty Surgery, Section of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology; Columbia University Irving Medical Center, New York, NY.
Obstet Gynecol
November 2023
New York-Presbyterian/Columbia University Irving Medical Center and the Icahn School of Medicine at Mount Sinai, New York, and the Long Island Jewish Medical Center, New Hyde Park, New York; The Ohio State University-Wexner Medical Center and OhioHealth, Columbus, and the Women's Health Institute, Cleveland Clinic, and Case Western Reserve University, University Hospitals Cleveland, Cleveland, Ohio; Ochsner Health, New Orleans, Louisiana; the West Virginia University School of Medicine and Charleston Area Medical Center, Charleston, West Virginia; The Mother Baby Center at Abbott Northwestern Hospital, Minneapolis, Minnesota; ChristianaCare Health System, Newark, Delaware; Loma Linda University Children's Hospital, Loma Linda, and Alydia Health Inc, Menlo Park, California; the University of Utah Health, Salt Lake City, Utah; Organon & Co., Jersey City, New Jersey; and the University of Pittsburgh Medical Center-Magee Women's Hospital, Pittsburgh, Pennsylvania.
Objective: To assess the real-world effectiveness and safety of a U.S. Food and Drug Administration (FDA)-cleared intrauterine vacuum-induced-hemorrhage control device for postpartum hemorrhage (PPH) management.
View Article and Find Full Text PDFJ Pediatr Adolesc Gynecol
February 2024
Cleveland Clinic, Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland, Ohio.
Fertil Steril
December 2023
Women's Health Institute, Cleveland Clinic, Cleveland, Ohio.
Context And Background: The prevalence of uterine fibroids is estimated to be approximately 80%. Fibroids can be associated with abnormal uterine bleeding, pressure symptoms, and infertility. Given this high prevalence, approximately 30,000 myomectomies are performed in the United States per year.
View Article and Find Full Text PDFInt Urogynecol J
December 2023
Center for Urogynecology & Pelvic Reconstructive Surgery, Subspecialty Care for Women's Health, Women's Health Institute, Cleveland Clinic, 9500 Euclid Avenue, A81, Cleveland, OH, 44195, USA.
Introduction And Hypothesis: There are sparse data on the use of postoperative pelvic floor physical therapy (PFPT) in patients undergoing vaginoplasty. The primary objective of this study was to compare the impact of PFPT on the ease of vaginal dilation after vaginoplasty in transgender women. We hypothesized that patients undergoing PFPT would report better ease of vaginal dilation following surgery.
View Article and Find Full Text PDFClin Transl Oncol
May 2024
Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, València, Spain.
Purpose: The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results.
Methods: We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen.
BJOG
February 2024
Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, USA.
Objective: Our objective was to perform a 5-year cost-effectiveness analysis of transvaginal hysteropexy (HP) via sacrospinous ligament fixation (SS) or uterosacral ligament suspension (US) versus vaginal hysterectomy (VH) with apical suspension via sacrospinous ligament fixation (SS) or uterosacral ligament suspension (US) for the treatment of uterine prolapse.
Design: A decision analytic model assessed the cost-effectiveness of the surgical intervention over a 5-year horizon.
Setting: This model was constructed using TreeAge® software.
Int Urogynecol J
December 2023
Center for Urogynecology and Pelvic Reconstructive Surgery, Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA.
Introduction And Hypothesis: To perform a cost-effectiveness analysis of concurrent posterior repair performed at the time of laparoscopic hysterectomy with sacrocolpopexy over a 7-year time period. We hypothesize it is not cost-effective to perform a posterior colporrhaphy.
Methods: We used TreeAge Pro® to construct a decision model with Markov modeling to compare sacrocolpopexy with and without concurrent posterior repair (SCP and SCP+PR) over a time horizon of 7 years.
AACN Adv Crit Care
September 2023
Cara D. Dolin is a Maternal Fetal Medicine Specialist, Ob/Gyn and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio.
Point-of-care ultrasonography (POCUS) is a tool that can be used to evaluate critically ill obstetric patients, in the same way as for nonpregnant patients. With knowledge of the physiology and anatomical changes of pregnancy, POCUS can provide meaningful information to help guide clinical management. A POCUS cardiothoracic evaluation for left and right ventricular function, pulmonary edema, pleural effusion, and pneumothorax can be performed in pregnancy.
View Article and Find Full Text PDFSurg Endosc
December 2023
Center for Abdominal Core Health, Department of General Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, A10-429, Cleveland, OH, 44195, USA.
Background: Tension-free abdominal closure is a primary tenet of laparotomy. But this concept neglects the baseline tension of the abdominal wall. Ideally, abdominal closure should be tailored to restore native physiologic tension.
View Article and Find Full Text PDFInt J Gynecol Cancer
November 2023
Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, Florida, USA
Endometrial cancer is the most common gynecologic malignancy in developed countries, with increasing incidence and mortality rates worldwide. While most cases are successfully treated with surgery, first-line treatment options for metastatic or recurrent endometrial cancer involve significant toxicities. Imprecise classification of heterogeneous subgroups further complicates treatment decisions and interpretation of clinical trial results.
View Article and Find Full Text PDFHealth Equity
August 2023
Section of Minimally Invasive Gynecologic Surgery, Obstetrics, Gynecology, and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
In this narrative review, we describe historical and contemporary influences that prevent patients with fibroids from getting appropriate medical care. Using patient stories as examples, we highlight how misogyny on all levels hurts patients and prevents medical teams from doing their best. Importantly, inequity and disparities result in massive gaps in care delivery.
View Article and Find Full Text PDFJCO Precis Oncol
August 2023
Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH.
Obstet Gynecol Surv
August 2023
Professor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC.
Importance: Genetic carrier screening is performed to identify carriers of rare genetic diseases. Identification of carriers allows patients to make informed reproductive health choices and can decrease the incidence of genetic disorders with serious medical implications.
Objective: This review aims to provide an overview of the history of prenatal genetic screening and the various forms of carrier screening, a synopsis of recent changes in society recommendations and current practice guidelines, and discussion of clinical challenges associated with carrier screening.
Psychological and cultural evolutionary accounts of human sociality propose that beliefs in punitive and monitoring gods that care about moral norms facilitate cooperation. While there is some evidence to suggest that belief in supernatural punishment and monitoring generally induce cooperative behaviour, the effect of a deity's moral concerns on cooperation remains unclear. Here, we report a pre-registered set of analyses to assess whether perceiving a locally relevant deity as moralistic predicts cooperative play in two permutations of two economic games using data from up to 15 diverse field sites.
View Article and Find Full Text PDFAnn Surg Oncol
October 2023
Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Background: Alternative service delivery models are critically needed to address the increasing demand for genetics services and limited supply of genetics experts available to provide pre-test counseling.
Methods: We conducted a prospective randomized controlled trial of women with stage 0-III breast cancer not meeting National Comprehensive Cancer Network (NCCN) criteria for genetic testing. Patients were randomized to pre-test counseling with a Chatbot or a certified genetic counselor (GC).
Urogynecology (Phila)
February 2024
From the Department of Colon and Rectal Surgery, Digestive Disease and Surgery Institute.
Urogynecology (Phila)
February 2024
Center for Urogynecology and Pelvic Reconstructive Surgery, Women's Health Institute, Cleveland Clinic, Cleveland, OH.
Importance: There is currently a paucity of data describing the outcomes of women with pelvic organ prolapse (POP) and/or urinary incontinence (UI) who present with pessary-related complications.
Objective: This study aimed to describe outcomes in women with POP and UI managed with a pessary who present with pessary-related complications.
Study Design: This was a retrospective cohort study of women with POP and/or UI who elected for management with a pessary from January 1, 2016, to December 31, 2020.
Obstet Gynecol
September 2023
Division of Gynecologic Oncology, Obstetrics, Gynecology and Women's Health Institute, and the Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, and the Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio.
Objective: To investigate whether clinical trial participation is associated with overall survival in patients with platinum-resistant ovarian cancer.
Methods: An IRB-approved, retrospective, single-institution cohort study was performed in patients with platinum-resistant ovarian cancer from January 1, 2009, to December 31, 2017. Platinum resistance was defined as progression within 6 months after completion of platinum chemotherapy.
J Clin Med
July 2023
Department of Obstetrics and Gynecology, HFR-Hòpital Fribourgeois, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland.
Adenomyosis is a commonly diagnosed benign condition characterized by the presence of ectopic endometrial glands within the underlying myometrium. The most common presenting signs and symptoms are abnormal uterine bleeding, chronic pelvic pain, and infertility. The clinical relevance of this condition is evident in both medical and surgical care.
View Article and Find Full Text PDFContraception
December 2023
Divisions of Clinical Research & Family Planning, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Division of Family Planning, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, United States.
Fertil Steril
October 2023
Department Obstetrics Gynecology, UAZ COMP / Banner University Medical Center, Phoenix, Arizona.